Rise Advisors, LLC Adma Biologics, Inc. Transaction History
Rise Advisors, LLC
- $220 Million
- Q1 2025
A detailed history of Rise Advisors, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 538 shares of ADMA stock, worth $10,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
538Holding current value
$10,808% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
379Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$375 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$338 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$258 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$230 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$114 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.94B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...